Cyclerion Therapeutics Inc

NASDAQ:CYCN 1:08:32 PM EDT

3.05

-0.45 (-12.86%)

Cyclerion Therapeutics Inc Stock, NASDAQ:CYCN

Riverview II, 245 First Street, Cambridge, Massachusetts 02142

United States of America

Phone: +1.857.327.8778

Number of Employees: 1

http://www.cyclerion.com

Description

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.